Global Small Molecule Anti-tumor Targted Drug Market Growth (Status and Outlook) 2020-2025


Sep, 2020 | Report ID: 149878 | 131 | Pharmaceuticals and Healthcare

According to this study, over the next five years the Small Molecule Anti-tumor Targted Drug market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Small Molecule Anti-tumor Targted Drug business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Small Molecule Anti-tumor Targted Drug market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Small Molecule Anti-tumor Targted Drug, covering the supply chain analysis, impact assessment to the Small Molecule Anti-tumor Targted Drug market size growth rate in several scenarios, and the measures to be undertaken by Small Molecule Anti-tumor Targted Drug companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.

EGFR

ALK

Bcr-Abl

Others

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.

Liver Cancer

Colorectal Cancer

Lung Cancer

Gastric Cancer

Breast Cancer

Esophageal Cancer

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Astrazeneca

Bristol-Myers Squibb

Novartis

Bayer

Exelixis

Millennium Pharmaceuticals

Eisai

Abbvie

Pfizer

Boehringer-Ingelheim

Roche

Bettapharma

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Small Molecule Anti-tumor Targted Drug market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

To understand the structure of Small Molecule Anti-tumor Targted Drug market by identifying its various subsegments.

Focuses on the key global Small Molecule Anti-tumor Targted Drug players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Small Molecule Anti-tumor Targted Drug with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the size of Small Molecule Anti-tumor Targted Drug submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Small Molecule Anti-tumor Targted Drug Market Size 2015-2025

2.1.2 Small Molecule Anti-tumor Targted Drug Market Size CAGR by Region

2.2 Small Molecule Anti-tumor Targted Drug Segment by Type

2.2.1 EGFR

2.2.2 EGFR

2.2.3 Bcr-Abl

2.2.4 Others

2.3 Small Molecule Anti-tumor Targted Drug Market Size by Type

2.3.1 Global Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type (2015-2020)

2.3.2 Global Small Molecule Anti-tumor Targted Drug Market Size Growth Rate by Type (2015-2020)

2.4 Small Molecule Anti-tumor Targted Drug Segment by Application

2.4.1 Liver Cancer

2.4.2 Colorectal Cancer

2.4.3 Lung Cancer

2.4.4 Gastric Cancer

2.4.5 Breast Cancer

2.4.6 Esophageal Cancer

2.4.7 Others

2.5 Small Molecule Anti-tumor Targted Drug Market Size by Application

2.5.1 Global Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application (2015-2020)

2.5.2 Global Small Molecule Anti-tumor Targted Drug Market Size Growth Rate by Application (2015-2020)

3 Global Small Molecule Anti-tumor Targted Drug by Players

3.1 Global Small Molecule Anti-tumor Targted Drug Market Size Market Share by Players

3.1.1 Global Small Molecule Anti-tumor Targted Drug Market Size by Players (2018-2020)

3.1.2 Global Small Molecule Anti-tumor Targted Drug Market Size Market Share by Players (2018-2020)

3.2 Global Small Molecule Anti-tumor Targted Drug Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Small Molecule Anti-tumor Targted Drug by Regions

4.1 Small Molecule Anti-tumor Targted Drug Market Size by Regions

4.2 Americas Small Molecule Anti-tumor Targted Drug Market Size Growth

4.3 APAC Small Molecule Anti-tumor Targted Drug Market Size Growth

4.4 Europe Small Molecule Anti-tumor Targted Drug Market Size Growth

4.5 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size Growth

5 Americas

5.1 Americas Small Molecule Anti-tumor Targted Drug Market Size by Countries

5.2 Americas Small Molecule Anti-tumor Targted Drug Market Size by Type

5.3 Americas Small Molecule Anti-tumor Targted Drug Market Size by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Small Molecule Anti-tumor Targted Drug Market Size by Regions

6.2 APAC Small Molecule Anti-tumor Targted Drug Market Size by Type

6.3 APAC Small Molecule Anti-tumor Targted Drug Market Size by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe Small Molecule Anti-tumor Targted Drug by Countries

7.2 Europe Small Molecule Anti-tumor Targted Drug Market Size by Type

7.3 Europe Small Molecule Anti-tumor Targted Drug Market Size by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Small Molecule Anti-tumor Targted Drug by Countries

8.2 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Type

8.3 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Small Molecule Anti-tumor Targted Drug Market Forecast

10.1 Global Small Molecule Anti-tumor Targted Drug Market Size Forecast (2021-2025)

10.2 Global Small Molecule Anti-tumor Targted Drug Forecast by Regions

10.2.1 Global Small Molecule Anti-tumor Targted Drug Forecast by Regions (2021-2025)

10.2.2 Americas Market Forecast

10.2.3 APAC Market Forecast

10.2.4 Europe Market Forecast

10.2.5 Middle East & Africa Market Forecast

10.3 Americas Forecast by Countries

10.3.1 United States Market Forecast

10.3.2 Canada Market Forecast

10.3.3 Mexico Market Forecast

10.3.4 Brazil Market Forecast

10.4 APAC Forecast by Countries

10.4.1 China Market Forecast

10.4.2 Japan Market Forecast

10.4.3 Korea Market Forecast

10.4.4 Southeast Asia Market Forecast

10.4.5 India Market Forecast

10.4.6 Australia Market Forecast

10.5 Europe Forecast by Countries

10.5.1 Germany Market Forecast

10.5.2 France Market Forecast

10.5.3 UK Market Forecast

10.5.4 Italy Market Forecast

10.5.5 Russia Market Forecast

10.5.6 Spain Market Forecast

10.6 Middle East & Africa Forecast by Countries

10.6.1 Egypt Market Forecast

10.6.2 South Africa Market Forecast

10.6.3 Israel Market Forecast

10.6.4 Turkey Market Forecast

10.6.5 GCC Countries Market Forecast

10.7 Global Small Molecule Anti-tumor Targted Drug Forecast by Type

10.8 Global Small Molecule Anti-tumor Targted Drug Forecast by Application

11 Key Players Analysis

11.1 Astrazeneca

11.1.1 Company Details

11.1.2 Small Molecule Anti-tumor Targted Drug Product Offered

11.1.3 Astrazeneca Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2018-2020)

11.1.4 Main Business Overview

11.1.5 Astrazeneca News

11.2 Bristol-Myers Squibb

11.2.1 Company Details

11.2.2 Small Molecule Anti-tumor Targted Drug Product Offered

11.2.3 Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2018-2020)

11.2.4 Main Business Overview

11.2.5 Bristol-Myers Squibb News

11.3 Novartis

11.3.1 Company Details

11.3.2 Small Molecule Anti-tumor Targted Drug Product Offered

11.3.3 Novartis Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2018-2020)

11.3.4 Main Business Overview

11.3.5 Novartis News

11.4 Bayer

11.4.1 Company Details

11.4.2 Small Molecule Anti-tumor Targted Drug Product Offered

11.4.3 Bayer Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2018-2020)

11.4.4 Main Business Overview

11.4.5 Bayer News

11.5 Exelixis

11.5.1 Company Details

11.5.2 Small Molecule Anti-tumor Targted Drug Product Offered

11.5.3 Exelixis Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2018-2020)

11.5.4 Main Business Overview

11.5.5 Exelixis News

11.6 Millennium Pharmaceuticals

11.6.1 Company Details

11.6.2 Small Molecule Anti-tumor Targted Drug Product Offered

11.6.3 Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2018-2020)

11.6.4 Main Business Overview

11.6.5 Millennium Pharmaceuticals News

11.7 Eisai

11.7.1 Company Details

11.7.2 Small Molecule Anti-tumor Targted Drug Product Offered

11.7.3 Eisai Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2018-2020)

11.7.4 Main Business Overview

11.7.5 Eisai News

11.8 Abbvie

11.8.1 Company Details

11.8.2 Small Molecule Anti-tumor Targted Drug Product Offered

11.8.3 Abbvie Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2018-2020)

11.8.4 Main Business Overview

11.8.5 Abbvie News

11.9 Pfizer

11.9.1 Company Details

11.9.2 Small Molecule Anti-tumor Targted Drug Product Offered

11.9.3 Pfizer Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2018-2020)

11.9.4 Main Business Overview

11.9.5 Pfizer News

11.10 Boehringer-Ingelheim

11.10.1 Company Details

11.10.2 Small Molecule Anti-tumor Targted Drug Product Offered

11.10.3 Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2018-2020)

11.10.4 Main Business Overview

11.10.5 Boehringer-Ingelheim News

11.11 Roche

11.12 Bettapharma

12 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology

Table 2. Data Source

Table 3. Small Molecule Anti-tumor Targted Drug Market Size CAGR by Region 2015-2025 ($ Millions)

Table 4. Major Players of EGFR

Table 5. Major Players of ALK

Table 6. Major Players of Bcr-Abl

Table 7. Major Players of Others

Table 8. Small Molecule Anti-tumor Targted Drug Market Size by Type (2014-2019) ($ Millions)

Table 9. Global Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type (2015-2020)

Table 10. Global Small Molecule Anti-tumor Targted Drug Market Size by Application (2015-2020) ($ Millions)

Table 11. Global Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application (2015-2020)

Table 12. Global Small Molecule Anti-tumor Targted Drug Revenue by Players (2018-2020) ($ Millions)

Table 13. Global Small Molecule Anti-tumor Targted Drug Revenue Market Share by Players (2018-2020)

Table 14. Global Small Molecule Anti-tumor Targted Drug Key Players Head office and Products Offered

Table 15. Small Molecule Anti-tumor Targted Drug Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global Small Molecule Anti-tumor Targted Drug Market Size by Regions 2015-2020 ($ Millions)

Table 19. Global Small Molecule Anti-tumor Targted Drug Market Size Market Share by Regions 2015-2020

Table 20. Americas Small Molecule Anti-tumor Targted Drug Market Size by Countries (2015-2020) ($ Millions)

Table 21. Americas Small Molecule Anti-tumor Targted Drug Market Size Market Share by Countries (2015-2020)

Table 22. Americas Small Molecule Anti-tumor Targted Drug Market Size by Type (2015-2020) ($ Millions)

Table 23. Americas Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type (2015-2020)

Table 24. Americas Small Molecule Anti-tumor Targted Drug Market Size by Application (2015-2020) ($ Millions)

Table 25. Americas Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application (2015-2020)

Table 26. APAC Small Molecule Anti-tumor Targted Drug Market Size by Regions (2015-2020) ($ Millions)

Table 27. APAC Small Molecule Anti-tumor Targted Drug Market Size Market Share by Regions (2015-2020)

Table 28. APAC Small Molecule Anti-tumor Targted Drug Market Size by Type (2015-2020) ($ Millions)

Table 29. APAC Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type (2015-2020)

Table 30. APAC Small Molecule Anti-tumor Targted Drug Market Size by Application (2015-2020) ($ Millions)

Table 31. APAC Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application (2015-2020)

Table 32. Europe Small Molecule Anti-tumor Targted Drug Market Size by Countries (2015-2020) ($ Millions)

Table 33. Europe Small Molecule Anti-tumor Targted Drug Market Size Market Share by Countries (2015-2020)

Table 34. Europe Small Molecule Anti-tumor Targted Drug Market Size by Type (2015-2020) ($ Millions)

Table 35. Europe Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type (2015-2020)

Table 36. Europe Small Molecule Anti-tumor Targted Drug Market Size by Application (2015-2020) ($ Millions)

Table 37. Europe Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application (2015-2020)

Table 38. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Countries (2015-2020) ($ Millions)

Table 39. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size Market Share by Countries (2015-2020)

Table 40. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Type (2015-2020) ($ Millions)

Table 41. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type (2015-2020)

Table 42. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Application (2015-2020) ($ Millions)

Table 43. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application (2015-2020)

Table 44. Key and Potential Regions of Small Molecule Anti-tumor Targted Drug

Table 45. Key Application and Potential Industries of Small Molecule Anti-tumor Targted Drug

Table 46. Key Challenges of Small Molecule Anti-tumor Targted Drug

Table 47. Key Trends of Small Molecule Anti-tumor Targted Drug

Table 48. Global Small Molecule Anti-tumor Targted Drug Market Size Forecast by Regions (2021-2025) ($ Millions)

Table 49. Global Small Molecule Anti-tumor Targted Drug Market Size Market Share Forecast by Regions

Table 50. Global Small Molecule Anti-tumor Targted Drug Market Size Forecast by Type (2021-2025) ($ Millions)

Table 51. Global Small Molecule Anti-tumor Targted Drug Market Size Market Share Forecast by Type (2021-2025)

Table 52. Global Small Molecule Anti-tumor Targted Drug Market Size Forecast by Application (2021-2025) ($ Millions)

Table 53. Global Small Molecule Anti-tumor Targted Drug Market Size Market Share Forecast by Application (2021-2025)

Table 54. Astrazeneca Details, Company Total Revenue (in $ million), Head Office, Small Molecule Anti-tumor Targted Drug Major Market Areas and Its Competitors

Table 55. Astrazeneca Small Molecule Anti-tumor Targted Drug Product Offered

Table 56. Astrazeneca Small Molecule Anti-tumor Targted Drug Revenue and Gross Margin (2018-2020E)

Table 57. Astrazeneca Main Business

Table 58. Astrazeneca Latest Developments

Table 59. Bristol-Myers Squibb Details, Company Total Revenue (in $ million), Head Office, Small Molecule Anti-tumor Targted Drug Major Market Areas and Its Competitors

Table 60. Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Product Offered

Table 61. Bristol-Myers Squibb Main Business

Table 62. Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Revenue and Gross Margin (2018-2020E)

Table 63. Bristol-Myers Squibb Latest Developments

Table 64. Novartis Details, Company Total Revenue (in $ million), Head Office, Small Molecule Anti-tumor Targted Drug Major Market Areas and Its Competitors

Table 65. Novartis Small Molecule Anti-tumor Targted Drug Product Offered

Table 66. Novartis Main Business

Table 67. Novartis Small Molecule Anti-tumor Targted Drug Revenue and Gross Margin (2018-2020E)

Table 68. Novartis Latest Developments

Table 69. Bayer Details, Company Total Revenue (in $ million), Head Office, Small Molecule Anti-tumor Targted Drug Major Market Areas and Its Competitors

Table 70. Bayer Small Molecule Anti-tumor Targted Drug Product Offered

Table 71. Bayer Main Business

Table 72. Bayer Small Molecule Anti-tumor Targted Drug Revenue and Gross Margin (2018-2020E)

Table 73. Bayer Latest Developments

Table 74. Exelixis Details, Company Total Revenue (in $ million), Head Office, Small Molecule Anti-tumor Targted Drug Major Market Areas and Its Competitors

Table 75. Exelixis Small Molecule Anti-tumor Targted Drug Product Offered

Table 76. Exelixis Main Business

Table 77. Exelixis Small Molecule Anti-tumor Targted Drug Revenue and Gross Margin (2018-2020E)

Table 78. Exelixis Latest Developments

Table 79. Millennium Pharmaceuticals Details, Company Total Revenue (in $ million), Head Office, Small Molecule Anti-tumor Targted Drug Major Market Areas and Its Competitors

Table 80. Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Product Offered

Table 81. Millennium Pharmaceuticals Main Business

Table 82. Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Revenue and Gross Margin (2018-2020E)

Table 83. Millennium Pharmaceuticals Latest Developments

Table 84. Eisai Details, Company Total Revenue (in $ million), Head Office, Small Molecule Anti-tumor Targted Drug Major Market Areas and Its Competitors

Table 85. Eisai Small Molecule Anti-tumor Targted Drug Product Offered

Table 86. Eisai Main Business

Table 87. Eisai Small Molecule Anti-tumor Targted Drug Revenue and Gross Margin (2018-2020E)

Table 88. Eisai Latest Developments

Table 89. Abbvie Details, Company Total Revenue (in $ million), Head Office, Small Molecule Anti-tumor Targted Drug Major Market Areas and Its Competitors

Table 90. Abbvie Small Molecule Anti-tumor Targted Drug Product Offered

Table 91. Abbvie Main Business

Table 92. Abbvie Small Molecule Anti-tumor Targted Drug Revenue and Gross Margin (2018-2020E)

Table 93. Abbvie Latest Developments

Table 94. Pfizer Details, Company Total Revenue (in $ million), Head Office, Small Molecule Anti-tumor Targted Drug Major Market Areas and Its Competitors

Table 95. Pfizer Small Molecule Anti-tumor Targted Drug Product Offered

Table 96. Pfizer Main Business

Table 97. Pfizer Small Molecule Anti-tumor Targted Drug Revenue and Gross Margin (2018-2020E)

Table 98. Pfizer Latest Developments

Table 99. Boehringer-Ingelheim Details, Company Total Revenue (in $ million), Head Office, Small Molecule Anti-tumor Targted Drug Major Market Areas and Its Competitors

Table 100. Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Product Offered

Table 101. Boehringer-Ingelheim Main Business

Table 102. Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Revenue and Gross Margin (2018-2020E)

Table 103. Boehringer-Ingelheim Latest Developments

Table 104. Roche Details, Company Total Revenue (in $ million), Head Office, Small Molecule Anti-tumor Targted Drug Major Market Areas and Its Competitors

Table 105. Bettapharma Details, Company Total Revenue (in $ million), Head Office, Small Molecule Anti-tumor Targted Drug Major Market Areas and Its Competitors

List of Figures

Figure 1. Small Molecule Anti-tumor Targted Drug Report Years Considered

Figure 2. Market Research Methodology

Figure 3. Global Small Molecule Anti-tumor Targted Drug Market Size Growth Rate 2015-2025 ($ Millions)

Figure 4. Global Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type (2015-2020)

Figure 5. Global EGFR Market Size Growth Rate

Figure 6. Global ALK Market Size Growth Rate

Figure 7. Global Bcr-Abl Market Size Growth Rate

Figure 8. Global Others Market Size Growth Rate

Figure 9. Small Molecule Anti-tumor Targted Drug in Liver Cancer

Figure 10. Global Small Molecule Anti-tumor Targted Drug Market: Liver Cancer (2015-2020) ($ Millions)

Figure 11. Small Molecule Anti-tumor Targted Drug in Colorectal Cancer

Figure 12. Global Small Molecule Anti-tumor Targted Drug Market: Colorectal Cancer (2015-2020) ($ Millions)

Figure 13. Small Molecule Anti-tumor Targted Drug in Lung Cancer

Figure 14. Global Small Molecule Anti-tumor Targted Drug Market: Lung Cancer (2015-2020) ($ Millions)

Figure 15. Global Lung Cancer YoY Growth ($ Millions)

Figure 16. Small Molecule Anti-tumor Targted Drug in Gastric Cancer

Figure 17. Global Small Molecule Anti-tumor Targted Drug Market: Gastric Cancer (2015-2020) ($ Millions)

Figure 18. Global Gastric Cancer YoY Growth ($ Millions)

Figure 19. Small Molecule Anti-tumor Targted Drug in Breast Cancer

Figure 20. Global Small Molecule Anti-tumor Targted Drug Market: Breast Cancer (2015-2020) ($ Millions)

Figure 21. Global Breast Cancer YoY Growth ($ Millions)

Figure 22. Global Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application in 2019

Figure 23. Global Small Molecule Anti-tumor Targted Drug Market Size Market Share by Regions 2015-2020

Figure 24. Americas Small Molecule Anti-tumor Targted Drug Market Size 2015-2020 ($ Millions)

Figure 25. APAC Small Molecule Anti-tumor Targted Drug Market Size 2015-2020 ($ Millions)

Figure 26. Europe Small Molecule Anti-tumor Targted Drug Market Size 2015-2020 ($ Millions)

Figure 27. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size 2015-2020 ($ Millions)

Figure 28. Americas Small Molecule Anti-tumor Targted Drug Market Size Market Share by Countries in 2019

Figure 29. Americas Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type in 2019

Figure 30. Americas Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application in 2019

Figure 31. United States Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)

Figure 32. Canada Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)

Figure 33. Mexico Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)

Figure 34. APAC Small Molecule Anti-tumor Targted Drug Market Size Market Share by Regions in 2019

Figure 35. APAC Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type in 2019

Figure 36. APAC Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application in 2019

Figure 37. China Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)

Figure 38. Japan Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)

Figure 39. Korea Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)

Figure 40. Southeast Asia Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)

Figure 41. India Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)

Figure 42. Australia Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)

Figure 43. Europe Small Molecule Anti-tumor Targted Drug Market Size Market Share by Countries in 2019

Figure 44. Europe Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type in 2019

Figure 45. Europe Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application in 2019

Figure 46. Germany Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)

Figure 47. France Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)

Figure 48. UK Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)

Figure 49. Italy Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)

Figure 50. Russia Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)

Figure 51. Spain Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)

Figure 52. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size Market Share by Countries in 2019

Figure 53. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type in 2019

Figure 54. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application in 2019

Figure 55. Egypt Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)

Figure 56. South Africa Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)

Figure 57. Israel Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)

Figure 58. Turkey Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)

Figure 59. GCC Countries Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)

Figure 60. Global Small Molecule Anti-tumor Targted Drug arket Size Forecast (2021-2025) ($ Millions)

Figure 61. Americas Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)

Figure 62. APAC Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)

Figure 63. Europe Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)

Figure 64. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)

Figure 65. United States Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)

Figure 66. Canada Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)

Figure 67. Mexico Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)

Figure 68. Brazil Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)

Figure 69. China Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)

Figure 70. Japan Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)

Figure 71. Korea Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)

Figure 72. Southeast Asia Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)

Figure 73. India Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)

Figure 74. Australia Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)

Figure 75. Germany Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)

Figure 76. France Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)

Figure 77. UK Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)

Figure 78. Italy Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)

Figure 79. Russia Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)

Figure 80. Spain Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)

Figure 81. Egypt Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)

Figure 82. South Africa Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)

Figure 83. Israel Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)

Figure 84. Turkey Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)

Figure 85. GCC Countries Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)

Sample Request is not available